SANOFI.BO

SANOFI.BO

BSE

Sanofi India Limited

3501.4

-85.8(-2.39%)
Volume

0.0M

Market Cap

$80.64B

P/E Ratio

28.81

EPS

$141.85


Price Chart

Price Alerts

No price alerts set. Add an alert to get notified!

Notify when price goes above $120.00
Notify when price goes above $180.00
Notify when price goes below $180.00

Key Financial Ratios

P/E Ratio

28.81

P/B Ratio

12.56

EPS

$141.85

ROE

43.61%

Profit Margin

17.78%

Operating Margin

24.71%

Peer Comparison

Compare TSM with similar companies in the sector

Company Price Change % P/E Market Cap D/E
BLUEJET.BO
Blue Jet Healthcare Limited
$417.15 0.36% 24.64 $72.36B 0.02
BLUEJET.NS
Blue Jet Healthcare Limited
$417.00 0.41% 24.64 $72.34B 0.02
JLHL.BO
Jupiter Life Line Hospitals Limited
$1,291.10 -0.26% 44.96 $84.65B 0.28
JUBLINGREA.NS
Jubilant Ingrevia Limited
$698.95 6.10% 41.59 $110.24B 0.27
MARKSANS.BO
Marksans Pharma Limited
$179.60 1.53% 22.57 $81.39B 0.12
MARKSANS.NS
Marksans Pharma Limited
$179.56 1.58% 22.57 $81.37B 0.12
PGHL.BO
Procter & Gamble Health Limited
$5,133.90 0.95% 29.03 $85.22B 0.02
PGHL.NS
Procter & Gamble Health Limited
$5,132.90 0.96% 29.03 $85.20B 0.02
STAR.BO
Strides Pharma Science Limited
$1,001.80 0.42% 18.06 $92.34B 0.67
STAR.NS
Strides Pharma Science Limited
$1,002.05 0.51% 18.06 $92.36B 0.67

* Peer stocks are selected based on market capitalization and sector

Private Notes

Key Statistics

52 Week High

$6,717.50

52 Week Low

$3,151.05

Dividend

$192.00

Dividend Yield

4.70%

About Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, antihistamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.